Found: 16
Select item for more details and to access through your institution.
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00917-4
- By:
- Publication type:
- Article
Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma.
- Published in:
- Frontiers in Genetics, 2020, v. 11, p. 1, doi. 10.3389/fgene.2020.00814
- By:
- Publication type:
- Article
Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3553, doi. 10.3390/ijms24043553
- By:
- Publication type:
- Article
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1127, doi. 10.1111/bjh.18984
- By:
- Publication type:
- Article
Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 433, doi. 10.1111/bjh.16718
- By:
- Publication type:
- Article
Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 6, p. 884, doi. 10.1111/bjh.12295
- By:
- Publication type:
- Article
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
- Published in:
- Nature Genetics, 2011, v. 43, n. 10, p. 1012, doi. 10.1038/ng.913
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
p53-Dependent Transcriptional Responses to Interleukin-3 Signaling.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031428
- By:
- Publication type:
- Article
A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4019, doi. 10.3390/cancers15164019
- By:
- Publication type:
- Article
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0209-2
- By:
- Publication type:
- Article
The preferential occurrence of FLT3- TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 4, p. 557, doi. 10.1111/bjh.12131
- By:
- Publication type:
- Article
Editorial: Advances in the treatment of chronic myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1166588
- By:
- Publication type:
- Article
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40279-2
- By:
- Publication type:
- Article
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40279-2
- By:
- Publication type:
- Article